Invention Grant
- Patent Title: Somatic human cell line mutations
-
Application No.: US15100105Application Date: 2014-11-28
-
Publication No.: US10557151B2Publication Date: 2020-02-11
- Inventor: Tilmann Buerckstuemmer
- Applicant: HORIZON GENOMICS GMBH
- Applicant Address: GB Cambridge
- Assignee: Horizon Discovery Limited
- Current Assignee: Horizon Discovery Limited
- Current Assignee Address: GB Cambridge
- Agency: Bookoff McAndrews, PLLC
- Priority: EP13194939 20131128; EP13194940 20131128; WOPCT/EP2014/066732 20140804; EP14181367 20140819; EP14191914 20141105
- International Application: PCT/EP2014/076028 WO 20141128
- International Announcement: WO2015/079056 WO 20150604
- Main IPC: C12N15/90
- IPC: C12N15/90 ; C12N5/071 ; C12Q1/6813 ; C12Q1/68

Abstract:
The invention provides for a method of producing a mutant somatic human cell line of cells comprising a genomic mutation of interest (MOI) at a predefined genomic site of interest (GOI) in close proximity to a genomic target site, which comprises: a) providing a guide RNA (gRNA) comprising a tracrRNA in conjunction with crRNA including an oligonucleotide sequence that hybridizes with the target site; b) providing an RNA-guided endonuclease which catalyzes the DNA break at the target site upon hybridizing with the gRNA; c) introducing the gRNA into the cells in the presence of the endonuclease to obtain a repertoire of cells comprising a variety of genomic mutations at the target site; d) selecting a cell from said repertoire which comprises a MOI; wherein the cell is haploid for the genomic locus of the target site; and e) expanding the cell to obtain the mutant cell line. The invention further provides for a mutant human somatic cell line obtainable by such method; and libraries of mutant human somatic cell lines of isogenic cells with a variety of genomic mutations at different predefined genomic target sites.
Public/Granted literature
- US20170009256A1 SOMATIC HUMAN CELL LINE MUTATIONS Public/Granted day:2017-01-12
Information query
IPC分类: